Screener
Travere Therapeutics, Inc. TVTX Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other income, net: | ||
| Interest income | 2,584 | 3,795 |
| Interest expense | (2,300) | (2,857) |
| Other (expense) income, net | (91) | 549 |
| Total other income, net | 193 | 1,487 |
| Loss from continuing operations before income tax | (36,722) | (41,187) |
| Income tax benefit (provision) on continuing operations | 120 | (39) |
| Loss from continuing operations, net of tax | (36,602) | (41,226) |
Item 1. Financial Statements
FAQ
- What is Travere Therapeutics, Inc.'s other income, net (note 6)?
- Travere Therapeutics, Inc. (TVTX) reported other income, net (note 6) of -$91K in Q1 2026.
- How has Travere Therapeutics, Inc.'s other income, net (note 6) changed year-over-year?
- Travere Therapeutics, Inc.'s other income, net (note 6) decreased by 116.6% year-over-year, from $549K to -$91K.
- What is the long-term trend for Travere Therapeutics, Inc.'s other income, net (note 6)?
- Over 4 years (2021 to 2025), Travere Therapeutics, Inc.'s other income, net (note 6) has grown at a 166.1% compound annual growth rate (CAGR), from $231K to $11.58M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.
Ask your AI about Travere Therapeutics, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude